Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1997 2
2006 1
2009 1
2010 2
2011 4
2012 10
2013 7
2014 1
2015 4
2016 1
2017 1
2019 1
2020 4
2021 11
2022 10
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, Tewari KS, Salman P, Hoyos Usta E, Yañez E, Gümüş M, Olivera Hurtado de Mendoza M, Samouëlian V, Castonguay V, Arkhipov A, Toker S, Li K, Keefe SM, Monk BJ; KEYNOTE-826 Investigators. Colombo N, et al. N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18. N Engl J Med. 2021. PMID: 34534429 Clinical Trial.
COVID-19 pandemic: changes in cancer admissions.
Guven DC, Aktas BY, Aksun MS, Ucgul E, Sahin TK, Yildirim HC, Guner G, Kertmen N, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Turker A, Uckun FM, Arik Z. Guven DC, et al. Among authors: arik z. BMJ Support Palliat Care. 2020 Jul 14:bmjspcare-2020-002468. doi: 10.1136/bmjspcare-2020-002468. Online ahead of print. BMJ Support Palliat Care. 2020. PMID: 32665259
Ovarian Carcinoma Presenting With a Large Cervical Mass.
Yilmaz MT, Gurlek E, Gultekin M, Kahraman K, Salman MC, Usubutun A, Akata D, Lay Ergun E, Arik Z, Yildiz F. Yilmaz MT, et al. Among authors: arik z. Cureus. 2022 Jan 6;14(1):e20994. doi: 10.7759/cureus.20994. eCollection 2022 Jan. Cureus. 2022. PMID: 35154969 Free PMC article.
PROPROTEIN CONVERTASE 1/3 DEFICIENCY WITH PELVIC EWING SARCOMA.
Oral H, Guven DC, Özdemir DA, Usubütün A, Gonc N, Arik Z. Oral H, et al. Among authors: arik z. Acta Endocrinol (Buchar). 2022 Oct-Dec;18(4):508-511. doi: 10.4183/aeb.2022.508. Acta Endocrinol (Buchar). 2022. PMID: 37152885 Free PMC article.
Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye.
Telli Dizman G, Metan G, Zarakolu P, Tanrıverdi ES, Hazırolan G, Aytaç Ak H, Kılınçarslan D, Uzun M, Çelik Kavaklılar B, Arık Z, Otlu B, Ünal S. Telli Dizman G, et al. Among authors: arik z. Healthcare (Basel). 2023 Sep 28;11(19):2641. doi: 10.3390/healthcare11192641. Healthcare (Basel). 2023. PMID: 37830678 Free PMC article.
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.
Karacin C, Sunar V, Urakci Z, Yilmaz A, Ayhan M, Ersoy M, Guven DC, Erturk I, Durmus Y, Karacin P, Boran N, Ustun YE, Meydan M, Dogan M, Oksuzoğlu B, Ates O, Karaca M, Uncu D, Ergun Y, Arik Z. Karacin C, et al. Among authors: arik z. Future Oncol. 2024 Feb;20(4):207-214. doi: 10.2217/fon-2023-0763. Epub 2024 Feb 8. Future Oncol. 2024. PMID: 38328890
57 results